Patent Ductus Arteriosus in the Preterm Infant
Author:
- Ronald I. ClymanRCRonald I. Clyman
- 29 May 2023
- book chapter
- Published by Elsevier
- p. 716-726.e11
Abstract
No abstract availableKeywords
This publication has 404 references indexed in Scilit:
- Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosusPediatric Research, 2012
- PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birthProstaglandins & Other Lipid Mediators, 2012
- Alagille syndrome: pathogenesis, diagnosis and managementEuropean Journal of Human Genetics, 2011
- Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3European Journal of Human Genetics, 2010
- Inadvertent Relaxation of the Ductus Arteriosus by Pharmacologic Agents that are Commonly Used in the Neonatal PeriodSeminars in Perinatology, 2010
- T-type Ca2+ Channels Promote Oxygenation-induced Closure of the Rat Ductus Arteriosus Not Only by Vasoconstriction but Also by Neointima FormationJournal of Biological Chemistry, 2009
- The Role of Patent Ductus Arteriosus Ligation in Bronchopulmonary Dysplasia: Reexamining a Randomized Controlled TrialThe Journal of Pediatrics, 2009
- Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest developmentProceedings of the National Academy of Sciences, 2008
- Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouseBritish Journal of Pharmacology, 2008
- Patent Ductus Arteriosus: Evidence for and against TreatmentThe Journal of Pediatrics, 2007